A Strategy for Regulatory Action When New Adverse Effects of a Licensed Product Emerge

JK Aronson, D Price, Robin Ferner

Research output: Contribution to journalArticle

13 Citations (Scopus)
Original languageEnglish
Pages (from-to)91-98
Number of pages8
JournalDrug Safety
Volume32
Issue number2
DOIs
Publication statusPublished - 1 Jan 2009

Cite this